Menu
GeneBe

rs587776640

Variant summary

Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong

The NM_004629.2(FANCG):c.637_643del(p.Tyr213LysfsTer6) variant causes a frameshift change. The variant allele was found at a frequency of 0.00000929 in 1,614,220 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.

Frequency

Genomes: 𝑓 0.000013 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0000089 ( 0 hom. )

Consequence

FANCG
NM_004629.2 frameshift

Scores

Not classified

Clinical Significance

Pathogenic criteria provided, multiple submitters, no conflicts P:9

Conservation

PhyloP100: 4.92
Variant links:
Genes affected
FANCG (HGNC:3588): (FA complementation group G) The Fanconi anemia complementation group (FANC) currently includes FANCA, FANCB, FANCC, FANCD1 (also called BRCA2), FANCD2, FANCE, FANCF, FANCG, FANCI, FANCJ (also called BRIP1), FANCL, FANCM and FANCN (also called PALB2). The previously defined group FANCH is the same as FANCA. Fanconi anemia is a genetically heterogeneous recessive disorder characterized by cytogenetic instability, hypersensitivity to DNA crosslinking agents, increased chromosomal breakage, and defective DNA repair. The members of the Fanconi anemia complementation group do not share sequence similarity; they are related by their assembly into a common nuclear protein complex. This gene encodes the protein for complementation group G. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Pathogenic. Variant got 18 ACMG points.

PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 9-35077266-TGGCGGTA-T is Pathogenic according to our data. Variant chr9-35077266-TGGCGGTA-T is described in ClinVar as [Pathogenic]. Clinvar id is 6719.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-35077266-TGGCGGTA-T is described in Lovd as [Pathogenic].

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
FANCGNM_004629.2 linkuse as main transcriptc.637_643del p.Tyr213LysfsTer6 frameshift_variant 5/14 ENST00000378643.8

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
FANCGENST00000378643.8 linkuse as main transcriptc.637_643del p.Tyr213LysfsTer6 frameshift_variant 5/141 NM_004629.2 P2

Frequencies

GnomAD3 genomes
AF:
0.00000657
AC:
1
AN:
152222
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.00000795
AC:
2
AN:
251450
Hom.:
0
AF XY:
0.00000736
AC XY:
1
AN XY:
135898
show subpopulations
Gnomad AFR exome
AF:
0.0000615
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.0000327
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000889
AC:
13
AN:
1461880
Hom.:
0
AF XY:
0.00000963
AC XY:
7
AN XY:
727238
show subpopulations
Gnomad4 AFR exome
AF:
0.000239
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000232
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00
Gnomad4 OTH exome
AF:
0.0000497
GnomAD4 genome
AF:
0.0000131
AC:
2
AN:
152340
Hom.:
0
Cov.:
32
AF XY:
0.0000134
AC XY:
1
AN XY:
74494
show subpopulations
Gnomad4 AFR
AF:
0.0000481
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00

ClinVar

Significance: Pathogenic
Submissions summary: Pathogenic:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Fanconi anemia complementation group G Pathogenic:5
Pathogenic, no assertion criteria providedclinical testingBaylor GeneticsApr 25, 2015Our laboratory reported dual molecular diagnoses in FANCG (NM_004629.1, c.637_643del) and G6PD (NM_001042351.1, c.563C>T) in one individual with reported features of intrauterine growth restriction, profound motor and speech delay, intellectual disability, macrocephaly, progressive hydrocephalus, congenital occipital encephalocele, bilateral sensorineural hearing loss, short stature, dysmorphic features, vision loss, congenital right unilateral hypoplasia of depressor anguli oris, feeding difficulties, hypertonia in four extremities, hyperreflexia, joint stiffness, wound dehiscence, and G6PD deficiency. The apparently homozygous c.637_643del (p.Y213fs) FANCG variant has been reported as disease causing (OMIM:602956.0008; PMID 15657175). An affected sibling, who had features consistent with Fanconi anemia, was also homozygous for this variant. -
Pathogenic, no assertion criteria providedliterature onlyOMIMMay 01, 2005- -
Pathogenic, no assertion criteria providedclinical testingNatera, Inc.Feb 05, 2021- -
Pathogenic, criteria provided, single submitterclinical testingKCCC/NGS Laboratory, Kuwait Cancer Control CenterApr 03, 2024This sequence change creates a premature translational stop signal (p.Tyr213Lysfs*6) in the FANCG gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in FANCG are known to be pathogenic (PMID: 12552564). This variant is present in population databases (rs587776640, gnomAD 0.007%). This premature translational stop signal has been observed in individuals with Fanconi anemia (FA) (PMID: 15657175, 24136620, 26968956). It is commonly reported in individuals of South African ancestry (PMID: 15657175, 24136620, 26968956). ClinVar contains an entry for this variant (Variation ID: 6719). For these reasons, this variant has been classified as Pathogenic.This sequence change creates a premature translational stop signal (p.Tyr213Lysfs*6) in the FANCG gene. It is expected to result in an absent or disrupted protein product. Loss-offunction variants in FANCG are known to be pathogenic (PMID: 12552564). This variant is present in population databases (rs587776640, gnomAD 0.007%). This premature translational stop signal has been observed in individuals with Fanconi anemia (FA) (PMID: 15657175, 24136620, 26968956). It is commonly reported in individuals of South African ancestry (PMID: 15657175, 24136620, 26968956). ClinVar contains an entry for this variant (Variation ID: 6719). For these reasons, this variant has been classified as Pathogenic. -
Pathogenic, criteria provided, single submitterclinical testingRevvity Omics, RevvityDec 10, 2021- -
Fanconi anemia Pathogenic:3
Pathogenic, criteria provided, single submitterresearchDivision of Human Genetics, National Health Laboratory Service/University of the WitwatersrandJul 01, 2023- -
Pathogenic, criteria provided, single submitterclinical testingInvitaeSep 27, 2023This sequence change creates a premature translational stop signal (p.Tyr213Lysfs*6) in the FANCG gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in FANCG are known to be pathogenic (PMID: 12552564). This variant is present in population databases (rs587776640, gnomAD 0.007%). This premature translational stop signal has been observed in individuals with Fanconi anemia (FA) (PMID: 15657175, 24136620, 26968956). It is commonly reported in individuals of South African ancestry (PMID: 15657175, 24136620, 26968956). ClinVar contains an entry for this variant (Variation ID: 6719). For these reasons, this variant has been classified as Pathogenic. -
Pathogenic, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineJun 30, 2022The p.Tyr213LysfsX6 or c.637_643delTACCGCC variant in FANCG has been reported in the homozygous state in more than 50 individuals with Fanconi anemia (FA) (Morgan N. 2005 PMID: 15657175, Feben C. 2014 PMID: 24136620, Ghazwani Y. 2016 PMID: 26968956). This variand was identified in 0.006% (1/16256) of African chromosomes by gnomAD (http://gnomad.broadinstitute.org); however, this frequency is low enough to be consistent with a recessive carrier frequency. This variant is reported in ClinVar (variation ID: 6719). This variant is predicted to cause a frameshift, which alters the protein’s amino acid sequence beginning at position 213 and leads to a premature termination codon 6 amino acids downstream. Loss of function of the FANCG gene is an established disease mechanism in autosomal recessive FA. In summary, this variant meets criteria to be classified as pathogenic for autosomal recessive Fanconi anemia. ACMG/AMP criteria applied: PVS1, PS4, PM2_Supporting. -
not provided Pathogenic:1
Pathogenic, criteria provided, single submitterclinical testingGeneDxMay 24, 2022Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Published functional studies demonstrate no detectable FANCG protein in lymphoblastoid cell lines from individuals homozygous for this variant (Morgan et al., 2005); Common pathogenic variant in individual of black South African background, with more than 80% of affected individuals carrying this variant (Morgan et al., 2005; Feben et al., 2015); This variant is associated with the following publications: (PMID: 24300640, 25477267, 24136620, 15657175, 26968956, 27959697, 11126723, 29843852, 26596371, 26962299, 29154021, 28185119, 32529760, 27535533) -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs587776640; hg19: chr9-35077263; API